Questions? We are here to help.

(833) 965-2070

Free Claim Review

100% Confidential

Did you take Dupixent (injection) for a minimum of 6 consecutive months? *

Did you take Dupixent due to one of the following conditions? *

Did you develop Cutaneous T-Cell Lymphoma (CTCL) after starting Dupixent treatment? *

Do you have another attorney for this case? *

By checking this box, I provide my electronic signature and consent to receive marketing calls and/or texts to the number above from Justice Alert about a law firm in its network who may assist with my legal claim, including through the use of an autodialer and pre- recorded voice technology and even if my number is listed on a federal, state, or company- specific do-not-call list. Consent is not a condition for Justice Alert’s services. I also agree to the Privacy Policy and Terms (including mandatory arbitration and class waiver).

Free Consultation: Start with a no-obligation consultation to discuss your case and understand your options.
Comprehensive Case Evaluation: We thoroughly review the details of your case to build a strong claim on your behalf.
Aggressive Representation: We will fight tirelessly for the just compensation you’re due.

No up-front costs and no fees whatsoever unless you win

Dupixent & Cancer Lawsuits

We Are Attorneys Who Will Fight For You

Were you diagnosed with Cutaneous T-cell Lymphoma (CTCL), Mycosis fungoides, or Sezary syndrome, after taking the biologic medication Dupixent?

Fill out the form and get a free case evaluation today!

Investigating Potential Links to 
Lymphoma and Cutaneous T-Cell 
Lymphoma (CTCL)

You may be eligible to pursue a claim if the following apply:

You used Dupixent (dupilumab) injections continuously for at least 6 months, and
You were prescribed Dupixent to treat one of the following conditions:
- Eczema (atopic dermatitis)
- Asthma
- Chronic rhinosinusitis with nasal polyps
- Eosinophilic esophagitis (EoE)
- Chronic obstructive pulmonary disease (COPD)
- Mycosis fungoides
- Sézary syndrome
After starting Dupixent treatment, you were diagnosed with:
- Lymphoma, or
- Malignant Cutaneous T-Cell Lymphoma (CTCL)
Your diagnosis occurred typically more than one year after beginning Dupixent, and
You experienced warning signs such as:
- A persistent or spreading rash that did not improve
- New or worsening skin nodules
- Swollen lymph nodes
You are not currently represented by another law firm for this specific claim

Who May Qualify for a Dupixent Lawsuit?

This Website Is A Paid Legal Advertisement Once You Become A Client Of The Firm, Information Regarding Your Claim
May Be Transmitted In Compliance With Hipaa And House Bill 300. Legal Representation Is Not Offered Or Available In Tennessee

By clicking above, I agree to receive telephone calls and text messages at the telephone number provided above/below (including any mobile number provided) to our law firm. I understand that consent is not a condition to receive the services and that I may revoke my consent at any time. I also have read and agree to your Terms of Use and Privacy Policy.